Serpendipity: Enhanced antithrombotic activity of a novel recombinant heparin cofactor II.

被引：0
|
作者：
Bauman, SJ [1 ]
Church, FC [1 ]
机构：
[1] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3380
引用
收藏
页码：92B / 93B
页数：2
相关论文
共 50 条
  • [31] NEUTROPHIL CHEMOATTRACTANT ACTIVITY OF HEPARIN COFACTOR-II-PROTEINASE REACTION-PRODUCTS
    CHURCH, FC
    HOFFMAN, MR
    BROWN, RL
    PRATT, CW
    ROBERTS, HR
    CLINICAL RESEARCH, 1989, 37 (02): : A378 - A378
  • [32] Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals
    Aihara, K
    Azuma, H
    Takamori, N
    Kanagawa, Y
    Akaike, M
    Fujimura, M
    Yoshida, T
    Hashizume, S
    Kato, M
    Yamaguchi, H
    Kato, S
    Ikeda, Y
    Arase, T
    Kondo, A
    Matsumoto, T
    CIRCULATION, 2004, 109 (22) : 2761 - 2765
  • [33] NONENZYMATIC GLYCATION REDUCES HEPARIN COFACTOR-II ANTI-THROMBIN ACTIVITY
    CERIELLO, A
    MARCHI, E
    BARBANTI, M
    MILANI, MR
    GIUGLIANO, D
    QUATRARO, A
    LEFEBVRE, P
    DIABETOLOGIA, 1990, 33 (04) : 205 - 207
  • [34] Recombinant antithrombin III mutants with enhanced antithrombin activity without heparin
    Kato, H
    Nagaoka, N
    Mizui, Y
    Suzuki, S
    Suzuki, N
    Watanabe, H
    Suzuki, K
    Komeda, K
    Seto, T
    Hashimoto, A
    Yoshitake, S
    CIRCULATION, 1996, 94 (08) : 4336 - 4336
  • [35] IDENTIFICATION OF HEPARIN COFACTOR-II AS THE PRINCIPAL PLASMA COFACTOR FOR THE ANTITHROMBIN ACTIVITY OF PENTOSAN POLYSULFATE (SP54)
    SCULLY, MF
    KAKKAR, VV
    THROMBOSIS RESEARCH, 1984, 36 (02) : 187 - 194
  • [36] Plasma Heparin Cofactor II Activity Is Inversely Associated with the Development NAFLD in Patients with Diabetes
    Hara, Tomoyo
    Yamagami, Hiroki
    Masuda, Shiho
    Mitsui, Yukari
    Kurahashi, Kiyoe
    Yoshida, Sumiko
    Otoda, Toshiki
    Yuasa, Tomoyuki
    Kuroda, Akio
    Endo, Itsuro
    Matsuhisa, Munehide
    Abe, Masahiro
    Aihara, Ken-Ichi
    DIABETES, 2022, 71
  • [37] HISTIDINE-RICH GLYCOPROTEIN INHIBITS THE ANTITHROMBIN ACTIVITY OF HEPARIN COFACTOR-II IN THE PRESENCE OF HEPARIN OR DERMATAN SULFATE
    NIWA, M
    YAMAGISHI, R
    KONDO, SI
    SAKURAGAWA, N
    KOIDE, T
    THROMBOSIS RESEARCH, 1985, 37 (01) : 237 - 240
  • [38] Phenotypic correction of murine hemophilia A by a recombinant human FVIII-heparin cofactor II hybrid protein.
    Scheiflinger, F
    Höfferer, L
    Mitterer, A
    Turecek, PL
    Schwarz, HP
    Falkner, FG
    Dorner, F
    BLOOD, 1998, 92 (10) : 100B - 100B
  • [39] Evaluation of the hemostatic potential of a recombinant human FVIII-heparin cofactor II hybrid protein in a mouse model
    Scheiflinger, F
    Höfferer, L
    Mitterer, A
    Turecek, PL
    Schwarz, HP
    Falkner, FG
    Dorner, F
    Baxter, F
    THROMBOSIS AND HAEMOSTASIS, 1999, : 237 - 238
  • [40] The reaction of neutrophil elastase with plasma heparin cofactor II and a truncated, his-tagged recombinant derivative.
    Cunningham, MA
    Bhakta, V
    Sheffield, WP
    THROMBOSIS AND HAEMOSTASIS, 1999, : 519 - 519
12345